Fig. 3

Survival analysis based on EGFR mutation and PD-L1 expression. a-d: Kaplan-Meier survival graph comparing ADC patients with wildtype (WT) and mutant (mut) EGFR (a), ADC patients with negative and positive PD-L1 expression (b), as well as comparing negative and positive PD-L1 subgroups in ADC patients either with mut EGFR (C) or WT EGFR (D) as indicated. e, f: Kaplan-Meier survival graph comparing PD-L1 negative and positive SQCC patients (e) and comparing PD-L1 negative and positive SQCC patients with WT EGFR (f)